SGX queries Biolidics on timing of disclosure that authorities had approved its Covid-19 test kits
Medical technology firm says it made disclosure after it was certain kits could be commercialised
Add BT as a preferred source
Singapore
BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority (HSA) after it was certain that the kits could be commercialised.
In an exchange filing on Thursday, the firm also said it only received approval for the product to be manufactured and marketed under its own brand some time later.
TRENDING NOW
Changes to EV incentives, uncertainty over COE framework drive Category A premium to a new high in ‘re-run of 2025 mania’
Employers want AI-fluent employees. Hiring them is the challenge
What makes a good job? Feeling that you matter
Targeted credit relief: Vietnam steers funding to Vingroup, Sun Group, Masterise megaprojects
